PXR activation has been associated with increased severity of steatosis, obesity, insulin resistance and hypercholesterolemia as it enhances hepatic fatty acid uptake and lipogenesis, while it decreases β-oxidation [212,213]. This evidence concerns the gene NR1I2 and obesity due to melanocortin 4 receptor deficiency.